1. Home
  2. COLL vs UUUU Comparison

COLL vs UUUU Comparison

Compare COLL & UUUU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COLL
  • UUUU
  • Stock Information
  • Founded
  • COLL 2002
  • UUUU 1987
  • Country
  • COLL United States
  • UUUU United States
  • Employees
  • COLL N/A
  • UUUU N/A
  • Industry
  • COLL Biotechnology: Pharmaceutical Preparations
  • UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • COLL Health Care
  • UUUU Industrials
  • Exchange
  • COLL Nasdaq
  • UUUU Nasdaq
  • Market Cap
  • COLL 958.8M
  • UUUU 1.1B
  • IPO Year
  • COLL 2015
  • UUUU N/A
  • Fundamental
  • Price
  • COLL $31.60
  • UUUU $9.34
  • Analyst Decision
  • COLL Strong Buy
  • UUUU Strong Buy
  • Analyst Count
  • COLL 4
  • UUUU 3
  • Target Price
  • COLL $43.75
  • UUUU $8.42
  • AVG Volume (30 Days)
  • COLL 291.1K
  • UUUU 14.0M
  • Earning Date
  • COLL 08-07-2025
  • UUUU 08-01-2025
  • Dividend Yield
  • COLL N/A
  • UUUU N/A
  • EPS Growth
  • COLL N/A
  • UUUU N/A
  • EPS
  • COLL 1.25
  • UUUU N/A
  • Revenue
  • COLL $664,283,000.00
  • UUUU $69,586,000.00
  • Revenue This Year
  • COLL $20.23
  • UUUU N/A
  • Revenue Next Year
  • COLL $3.82
  • UUUU $232.36
  • P/E Ratio
  • COLL $25.23
  • UUUU N/A
  • Revenue Growth
  • COLL 17.17
  • UUUU 59.09
  • 52 Week Low
  • COLL $23.23
  • UUUU $3.20
  • 52 Week High
  • COLL $42.29
  • UUUU $9.52
  • Technical
  • Relative Strength Index (RSI)
  • COLL 61.58
  • UUUU 82.76
  • Support Level
  • COLL $31.53
  • UUUU $5.57
  • Resistance Level
  • COLL $32.95
  • UUUU $6.70
  • Average True Range (ATR)
  • COLL 0.88
  • UUUU 0.56
  • MACD
  • COLL 0.06
  • UUUU 0.33
  • Stochastic Oscillator
  • COLL 73.51
  • UUUU 95.58

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.

Share on Social Networks: